Prospective Natural History Study of POLG Disease
The PIONEER study is exploring a rare genetic condition called POLG disease, which affects mitochondria – the powerhouses of our cells. This research is a 'natural history study', meaning doctors will carefully watch how the condition develops and changes in people over several years, rather than testing a new medicine. By understanding the typical journey of POLG disease, including how symptoms appear and progress, researchers hope to create a clear picture of the illness. This detailed information is crucial for future drug development. It helps scientists design better trials and gives health authorities like the FDA the data they need to approve new treatments, ultimately bridging the gap between understanding the genetics of the disease and finding effective therapies.
At a glance
What is this study about?
This study is called PIONEER, and it's all about a rare genetic condition known as POLG disease. This condition affects something in our bodies called mitochondria, which are like tiny power stations inside our cells that give us energy. When these power stations don't work properly because of POLG disease, it can lead to a range of health problems.
The main goal of the PIONEER study is to understand how POLG disease naturally changes and develops over time. This is known as a 'natural history' study, meaning researchers are not testing a new medication or treatment. Instead, they are carefully observing and recording how the disease affects people, how symptoms appear and progress, and what challenges people face. This long-term observation helps build a clear picture of the disease's journey.
Why is this important? Because POLG disease is rare, there's a lot we still don't know about its progression. By gathering this detailed information from many people in different places, researchers can identify key points in the disease's development. This valuable knowledge then becomes a strong foundation for future research. It helps scientists understand what treatments might be needed and allows them to design better studies for new drugs, making it easier for health authorities to approve effective therapies down the line.
Key takeaways
- It's a 'natural history' study to understand how POLG disease develops over time.
- No new treatments are being tested in this study.
- Participation involves regular clinic visits for assessments over about three years.
- The study helps bridge the gap between genetic understanding and future drug development.
- Information gathered is vital for developing and approving new treatments for POLG disease.
- It's open to people of all ages (0-75) with a confirmed POLG disease diagnosis.
Who may be eligible?
To take part in the PIONEER study, you need to have a confirmed diagnosis of POLG disease. This means that genetic tests must have shown you have the POLG condition, and your symptoms also match the disease.
The study is open to both males and females of any age, from newborns up to 75 years old. For children, a parent or guardian will need to give permission, and the child themselves might also be asked if they want to take part, depending on their age.
However, some people won't be able to join. This includes if you have a different mitochondrial condition that isn't POLG disease, or if your genetic test for POLG showed changes that aren't clearly linked to the disease or are thought to be harmless. Also, if the study team thinks you might struggle to attend appointments or follow the study plan, or if you can't or don't want to give your consent to participate, you wouldn't be able to join. Finally, if you have another significant health problem that isn't related to POLG disease and might make it hard to get clear results from the study, you also wouldn't be eligible.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- I have a confirmed diagnosis of POLG disease from genetic tests.
- My doctors agree my symptoms fit POLG disease.
- I am between 0 and 75 years old.
- I am able and willing to attend regular study appointments for about three years.
- I don't have another significant health condition that would interfere with the study results.
- I can give my informed consent, or my parent/guardian can for me if I'm under 18.
What does participation involve?
If you take part in the PIONEER study, you won't be given any new medication or treatment. Instead, the study involves regular visits to a clinic over about three years. During these visits, the doctors and nurses will carry out various assessments to understand how your condition is progressing. This might include checking your overall health, doing specific tests to see how your different body systems are working, and checking your balance and coordination. You might also be asked to do simple tasks like placing pegs into holes to measure your dexterity. They will also take blood or urine samples to look for specific markers that can tell us more about the disease. All these assessments help researchers track how the disease changes over time.
Potential risks and benefits
Locations (21)
- University of California San DiegoVerified postcodeSan Diego, United States· Not yet recruiting
- Children's Hospital ColoradoVerified postcodeAurora, United States· Not yet recruiting
- Columbia University Irving Medical CenterVerified postcodeNew York, United States· Not yet recruiting
- Akron Children's HospitalVerified postcodeAkron, United States· Not yet recruiting
- Children's Hospital of Philadelphia-PhiladelphiaVerified postcodePhiladelphia, United States· Not yet recruiting
- Baylor HospitalVerified postcodeDallas, United States· Not yet recruiting
- UTHealth HoustonVerified postcodeHouston, United States· Not yet recruiting
- Prince of Wales Hospital, SydneyVerified postcodeSydney, Australia· Not yet recruiting
- Copenhagen University Hospital- CopenhagenVerified postcodeCopenhagen, Denmark· Not yet recruiting
- Children's Hospital, Helsinki University Hospital-HelsinkiVerified postcodeHelsinki, Finland· Not yet recruiting
- Oulu University Hospital-OuluVerified postcodeHelsinki, Finland· Not yet recruiting
- Maastricht University-MaastrichtVerified postcodeMaastricht, Netherlands· Not yet recruiting
Common questions
What is POLG disease?
POLG disease is a rare genetic condition that affects mitochondria, which are like the power stations inside our cells. When they don't work correctly, it can cause various health problems.
Is this study testing a new medicine?
No, this is a 'natural history' study. It means researchers are observing how POLG disease progresses over time, not testing a new drug or treatment.
How long will I need to be in the study?
The study aims to follow participants for about three years to see how the condition changes over this period.
Will I get any treatment if I join?
The study itself doesn't provide any treatment. Your doctors will continue to manage your care as usual outside of the study.
What happens to my information?
Your personal information will be kept confidential. The study uses the information to understand POLG disease better, and individual participants are not identified in the results.
How to find out more
PIONEER
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.